Subclinical cardiovascular damage and fat utilization in overweight/obese individuals receiving the same dietary and pharmacological interventions

Nutrients

Volumn 6, Issue 12, 2014, Pages 5560-5571

  Montalcini, Tiziana ^a   Lamprinoudi, Theodora ^a   Gorgone, Gaetano ^a   Ferro, Yvelise ^a   Romeo, Stefano ^a,b   Pujia, Arturo ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cardiac remodeling; Carotid; Echocardiography; Fat utilization; Nutrient utilization; Obesity

Indexed keywords

CALCIUM; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FAT; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID; ANTIHYPERTENSIVE AGENT;

ADULT; AORTA ROOT; AREA UNDER THE CURVE; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CALORIMETRY; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CLINICAL ARTICLE; DIABETES MELLITUS; DIETARY INTAKE; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; EXTRACELLULAR FLUID; FAT FREE MASS; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART RATE; HEART VENTRICLE REMODELING; HIP CIRCUMFERENCE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MENOPAUSE; MUSCLE MASS; NUTRIENT UPTAKE; OBESITY; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY QUOTIENT; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SMOKING; TOTAL BODY WATER; WAIST CIRCUMFERENCE; ASYMPTOMATIC DISEASE; CALORIC RESTRICTION; CARDIOVASCULAR DISEASES; CHI SQUARE DISTRIBUTION; COMPLICATION; DOPPLER ECHOCARDIOGRAPHY; DOPPLER ECHOGRAPHY; ENERGY METABOLISM; IMPEDANCE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OVERWEIGHT; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME;

ADIPOSITY; ADULT; ANTIHYPERTENSIVE AGENTS; AREA UNDER CURVE; ASYMPTOMATIC DISEASES; BODY MASS INDEX; CALORIC RESTRICTION; CALORIMETRY; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY, DOPPLER; ELECTRIC IMPEDANCE; ENERGY METABOLISM; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; OBESITY; OVERWEIGHT; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 84914680432     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6125560     Document Type: Article

References (39)

1. Stanley, W.C.; Recchia, F.A.; Lopaschuk, G.D. Review myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 2005, 85, 1093-1129.
2. Ussher, J.R.; Wang, W.; Gandhi, M.; Keung, W.; Samokhvalov, V.; Oka, T.; Wagg, C.S.; Jaswal, J.S.; Harris, R.A.; Clanachan, A.S.; et al. Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury. Cardiovasc. Res. 2012, 94, 359-369.
3. Shrafian, H.; Frenneaux, M.P.; Opie, L.H. Metabolic mechanisms in heart failure. Circulation 2007, 116, 434-448.
4. Christe, M.E.; Rodgers, R.L. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J. Mol. Cell. Cardiol. 1994, 26, 1371-1374.
5. Zurlo, F.; Lillioja, S.; Esposito-Del Puente, A.; Nyomba, B.L.; Raz, I.; Saad, M.F.; Swinburn, B.A.; Knowler, W.C.; Bogardus, C.; Ravussin, E. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: Study of 24-h RQ. Am. J. Physiol. 1990, 259, 650-657.
6. Ferro, Y.; Gazzaruso, C.; Coppola, A.; Migliaccio, V.; Romeo, S.; Giustina, A.; Pujia, A.; Montalcini, T. Fat utilisationand arterial hypertension in overweight/obese subjects. J. Transl. Med. 2013, 11, doi:10.1186/1479-5876-11-159.
7. Montalcini, T.; Gazzaruso, C.; Ferro, Y.; Migliaccio, V.; Rotundo, S.; Castagna, A.; Pujia, A. Metabolic fuel utilisation and subclinical atherosclerosis in overweight/obese subjects. Endocrine. 2013, 44, 380-385.
8. Lorenz, M.W.; Markus, H.S.; Bots, M.L.; Rosvall, M.; Sitzer, M. Prediction of clinical cardiovascular events with carotid intima-media thickness-A systematic review and meta-analysis. Circulation 2007, 115, 459-467.
9. Di Bello, V.; Carerj, S.; Perticone, F.; Benedetto, F.; Palombo, C.; Talini, E.; Giannini, D.; la Carrubba, S.; Antonini-Canterin, F.; di Salvo, G. Carotid intima-media thickness in asymptomatic patients with arterial hypertension without clinical cardiovascular disease: Relation with left ventricular geometry and mass and coexisting risk factors. Angiology 2009, 60, 705-713.
10. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly. Hypertension 1994, 23, 275-285.
11. Psaty, B.M.; Furberg, C.D.; Kuller, L.H.; Bild, D.E.; Rautaharju, P.M.; Polak, J.F.; Bovill, E.; Gottdiener, J.S. Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: The cardiovascular health study. Arch. Intern. Med. 1999, 59, 1339-1347.
12. Montalcini, T.; Gorgone, G.; Fava, A.; Romeo, S.; Gazzaruso, C.; Pujia, A. Carotid and brachial arterial enlargement in postmenopausal women with hypertension. Menopause 2012, 9, 145-149.
13. Montalcini, T.; Gorgone, G.; Garzaniti, A.; Gazzaruso, C.; Pujia, A. Artery remodelling and abdominal adiposity in nonobese postmenopausal women. Eur. J. Clin. Nutr. 2010, 64, 1022-1024
14. Talluri, T.; Lietdke, R.J.; Evangelisti, A.; Talluri, J.; Maggia, G. Fat-free mass qualitative assessment with bioelectric impedance analysis (BIA). Ann. N. Y. Acad. Sci. 1999, 873, 94-98.
15. Zemel, M.B.; Bruckbauer, A. Effects of a leucine and pyridoxine-containing nutraceutical on fat oxidation, and oxidative and inflammatory stress in overweight and obese subjects. Nutrients 2012, 4, 529-541
16. Sahn, D.J.; de Maria, A.; Kisslo, J.; Weyman, A. The committee on M-mode standardization of the American society of echocardiography: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978, 58, 1072-1083.
17. Devereux, R.B.; Casale, P.N.; Kligfield, P.; Eisenberg, R.R.; Miller, D.; Campo, E.; Alonso, D.R. Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy. Am. J. Cardiol. 1986, 57, 1388-1393.
18. Valensise, H.; Novelli, G.P.; Vasapollo, B.; di Ruzza, G.; Romanini, M.E.; Marchei, M.; Larciprete, G.; Manfellotto, D.; Romanini, C.; Galante, A. Maternal diastolic dysfunction and left ventricular geometry in gestational hypertension. Hypertension 2001, 37, 1209-1215.
19. Dubois, D.; Dubois, E.F. A formula to estimate the approximate surface area if height and weight be known. Arch. Intern. Med. 1916, 17, 863-871.
20. Lang, R.M.; Bierig, M.; Devereux, R.B.; Flachskampf, E.; Foster, F.A.; Pellikka, P.A.; Picard, M.H.; Roman, M.J.; Seward, J.; Shanewise, J.M.; et al. Recommendations for chamber quantification. Eur. J. Echocardiogr. 2006, 7, 79-108.
21. Verdecchia, P.; Schillaci, G.; Borgioni, C.; Ciucci, A.; Battistelli, M.; Barroccini, C.; Santucci, A.; Santucci, C.; Reboldi, G.; Porcellati, C. Adverse prognostic significance of concentric remodelling of the left ventricle in hypertensive patients with normal left ventricular mass. J. Am. Coll. Cardiol. 1995, 25, 871-878.
22. Ganau, A.; Devereux, R.B.; Roman, M.J.; de Simone, G.; Pickering, T.G.; Saba, P.S.; Vargiu, P.; Simongini, I.; Laragh, J.H. Patterns of left ventricular hypertrophy and geometric remodelling in essential hypertension. J. Am. Coll. Cardiol. 1992, 19, 1550-1558.
23. Teichholz, L.E.; Kreulen, T.; Herman, M.V.; Gorlin, R. Problems in echocardiographic volume determinants: Echocardiographic-angiographic correlations in the presence or absence of asynergy. Am. J. Cardiol. 1976, 37, 7-11.
24. Pujia, A.; Gnasso, A.; Irace, C.; Colonna, A.; Mattioli, P.L. Common carotid arterial wall thickness in NIDDM subjects. Diabetes Care 1994, 17, 1330-1336.
25. Shah, A.M.; Hung, C.L.; Shin, S.H.; Skali, H.; Verma, A.; Ghali, J.K.; Køber, L.; Velazquez, E.J.; Rouleau, J.L.; McMurray, J.J.; et al. Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both. Am. Heart J. 2011, 162, 685-691.
26. Muiesan, M.L.; Salvetti, M.; Monteduro, C.; Bonzi, B.; Paini, A.; Viola, S.; Poisa, P.; Rizzoni, D.; Castellano, M.; Agabiti-Rosei, E. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 2004, 43, 731-738.
27. Klein, S.; Burke, L.E.; Bray, G.A.; Blair, S.; Allison, D.B.; Pi-Sunyer, X.; Hong, Y.; Eckel, R.H. Clinical implications of obesity with specific focus on cardiovascular disease: A statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation. Circulation 2004, 110, 2952-2967.
28. Antozzi, C.; Zeviani, M. Cardiomyopathies in disorders of oxidative metabolism. Cardiovasc. Res. 1997, 35, 184-199.
29. Jameel, M.N.; Zhang, J. Myocardial energetics in left ventricular hypertrophy. Curr. Cardiol. Rev. 2009, 5, 243-250.
30. Dyck, J.R.; Lopaschuk, G.D. Malonyl CoA control of fatty acid oxidation in the ischemic heart. J. Mol. Cell. Cardiol. 2002, 34, 1099-1109.
31. El Alaoui-Talibi, Z.; Guendouz, A.; Moravec, M.; Moravec, J. Control of oxidative metabolism in volume-overloaded rat hearts: Effect of propionyl-L-carnitine. Am. J. Physiol. 1997, 272, 1615-1624.
32. Kelly, D.P.; Mendelsohn, N.J.; Sobel, B.E.; Bergmann, S.R. Detection and assessment by positron emission tomography of a genetically determined defect in myocardial fatty acid utilisation (long-chain acyl-CoA dehydrogenase deficiency). Am. J. Cardiol. 1993, 71, 738-744.
33. Elia, M. Organ and tissue contribution to metabolic rate. In Energy Metabolism, Tissue Determinants and Cellular Corollaries; Kinney, J., Tucker, H., Eds.; Raven Press: New York, NY, USA, 1992; pp.61-80.
34. He, Q.; Heshka, S.; Albu, J.; Boxt, L.; Krasnow, N.; Elia, M.; Gallagher, D. Smaller organ mass with greater age, except for heart. J. Appl. Physiol. 2009, 106, 1780-1784.
35. Ito, M.; Adachi-Akahane, S. Inter-organ communication in the regulation of lipid metabolism: Focusing on the network between the liver, intestine, and heart. J. Pharmacol. Sci. 2013, 123, 312-317.
36. Panchal, S.K.; Ward, L.; Brown, L. Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Eur. J. Nutr. 2013, 52, 559-568.
37. Diwan, V.; Poudyal, H.; Brown, L. Piperine attenuates cardiovascular, liver and metabolic changes in high carbohydrate, high fat-fed rats. Cell Biochem. Biophys. 2013, 67, 297-304.
38. Park, C.; Guallar, E.; Linton, J.A.; Lee, D.C.; Jang, Y.; Son, D.K.; Han, E.J.; Baek, S.J.; Yun, Y.D.; Jee, S.H.; et al. Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases. Diabetes Care 2013, 36, 1988-1993.
39. Thijssen, D.H.; Black, M.A.; Pyke, K.E.; Padilla, J.; Atkinson, G.; Harris, R.A.; Parker, B.; Widlansky, M.E.; Tschakovsky, M.E.; Green, D.J. Assessment of flow-mediated dilation in humans: A methodological and physiological guideline. Am. J. Physiol. Heart Circ. Physiol. 2011, 300, 2-12.